Pharmaceutical

CRO Services Market Surges to USD 188.54 Billion by 2030, Propelled by 12.6% CAGR – Verified Market Reports®

LEWES, Del., Dec. 11, 2024 /PRNewswire/ --The CRO Services Market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource…

2 weeks ago

MM+M Announces Petauri’s Nicole Lodowski as 40 Under 40 Honoree for 2025

Rapidly growing pharmaceutical services platform leadership recognized for making significant contributions to healthcare marketing and communications. NASHVILLE, Tenn., Dec. 11, 2024…

2 weeks ago

DeepIntent Launches Pioneering Program to Elevate Third-Party Data Accountability

New Initiative Sets Standards in Data Vendor Compliance, Strengthening Client Confidence in Third-Party Data Sources NEW YORK, Dec. 11, 2024…

2 weeks ago

Signant Health Names Krishna Maridi, a Finance Leader with Over 25 Years of Experience, as Chief Financial Officer

PHILADELPHIA, Dec. 11, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the…

2 weeks ago

Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally

BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced…

2 weeks ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 – January 30, 2025

STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage…

2 weeks ago

Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024

Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation RALEIGH, NC /…

2 weeks ago

New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry

LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for…

2 weeks ago

Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology

KNOXVILLE, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today the…

2 weeks ago

60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is…

2 weeks ago